Last quarter (Q4 2023), Qualigen Therapeutics's total revenue was $-3.23M, a decrease of -324.43% from the same quarter last year. In Q4, Qualigen Therapeutics's net income was $-2.45M. See Qualigen Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Mar 20
Total Revenue	$ 1.39M	-	$ 4.98M	$ 5.65M	$ 2.85M	$ 5.56M
Cost of Revenue	$ 111.00K	-	-	-	$ 2.64M	$ 3.98M
Gross Profit	$ 1.39M	-	$ 4.98M	$ 5.65M	$ 209.41K	$ 1.58M
Operating Expense	$ 42.22M	$ 11.30M	$ 27.16M	$ 28.32M	$ 10.73M	$ 3.08M
Operating Income	$ -4.87M	$ -11.30M	$ -17.94M	$ -22.66M	$ -10.52M	$ -1.50M
Net Non Operating Interest Income Expense	$ -68.99K	$ -1.52M	$ 880.56K	$ 42.69K	$ -48.04K	$ -283.10K
Other Income Expense	$ -2.13M	$ -349.78K	$ -1.13K	$ -4.73M	$ -8.98M	$ 2.79K
Pretax Income	$ -18.05M	$ -12.48M	$ -21.30M	$ -17.89M	$ -19.55M	$ -1.78M
Tax Provision	$ 9.29M	$ 12.47M	$ -265.07K	$ 5.43K	$ 0.00	$ 4.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -6.72M	$ -13.42M	$ -18.64M	$ -17.90M	$ -19.55M	$ -1.79M
Basic EPS	$ -6.46	$ -2.65	$ -4.85	$ -178.97M	$ -1.12	$ -0.14
Diluted EPS	$ -1.94	$ -2.65	$ -4.85	$ -6.10	$ -1.12	$ -0.14
Basic Average Shares	$ 19.08M	$ 5.07M	$ 3.84M	$ 2.93M	$ 17.43M	$ 12.54M
Diluted Average Shares	$ 19.08M	$ 5.07M	$ 3.84M	$ 2.93M	$ 17.43M	$ 12.54M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 42.33M	$ 11.30M	$ 27.16M	$ 28.32M	$ 13.37M	$ 7.06M
Net Income From Continuing And Discontinued Operation	$ -18.79M	$ -13.42M	$ -21.03M	$ -17.90M	$ -19.55M	$ -1.79M
Normalized Income	$ -1.19M	$ -9.84M	-	-	$ -10.32M	$ -1.79M
Interest Expense	-	-	-	-	$ 48.04K	$ 283.10K
EBIT	$ -17.94M	$ -10.96M	$ -21.27M	$ -17.93M	$ -10.52M	$ -1.50M
EBITDA	$ -17.58M	$ -10.95M	$ -20.90M	$ -17.60M	$ -10.28M	$ -1.28M

Currency in USD

Qualigen Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing